Andrew A. Wilson, MD

NPI 1114000866ActiveIndividual· Internal Medicine, Pulmonary Disease· Boston, MA

Internal Medicine, Pulmonary Disease (MD) in Boston, Massachusetts, trained at University of Texas Southwestern Medical School at Dallas (class of 1999). Their prescriptions cost Medicare Part D more than their services did: $805,393 for 117 claims, against $1,683 paid for services in 2024. Takeda Pharmaceuticals U.S.A., Inc. reported $1,056 in payments in 2025, mostly consulting fees.

Overview

NPI	1114000866
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Oct 23, 2006
Last updated in NPPES	Jul 11, 2014

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Pulmonary Disease Primary	207RP1001X	217324	MA
Internal Medicine, Critical Care Medicine	207RC0200X	217324	MA
Internal Medicine	207R00000X	217324	MA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Pulmonary Disease (MA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	14
Services billed	16 across 2 procedure codes
Paid by Medicare	$1,683

Part D prescriptions in 2024

Prescriptions (claims)	117 · 131 30-day fills
Patients	11
Total drug cost	$805,393

Medicare sources and data years

Education and affiliations

Medical school	University of Texas Southwestern Medical School at Dallas
Graduation year	1999
Medicare specialty	Pulmonary Disease
Secondary specialties	Critical Care (Intensivists)